by Jazzmin Huber | Oct 5, 2023 | Research
We are pleased to announce that we have funded the creation and maintenance of the FOSTER consortium website. In the last 30 years there has been little change to osteosarcoma treatment or survival. We now have an opportunity to change this through the FOSTER (Fight...
by Tash Priya | Sep 21, 2023 | Clinical Trials, Research
Rare primary malignant bone sarcoma (RPMBS) is a term for rare bone cancers, and they account for no more than a tenth of fast-growing bone tumours. It can be difficult to research RPMBS as they are so rare. This slows down the development of new treatments. RPMBS...
by Jazzmin Huber | Aug 3, 2023 | Clinical Trials, Research
We were delighted to award Dr Tanya Heim a travel grant to present her work at FACTOR. Find out more about her work and FACTOR in her guest blog post. I have been a biomedical research scientist for over a decade. I have not always studied cancer, but I have always...
by Jazzmin Huber | Jul 20, 2023 | Clinical Trials, Research
Making it better for young people with Osteosarcoma is the mission of MIB Agents. Every year they bring together patients, families, doctors and researchers to drive forward research into bone cancer. This June the conference, called FACTOR, took place in Atlanta and...
by Jazzmin Huber | Jun 23, 2023 | Clinical Trials, Research
Every year cancer experts from across the world come together for The American Society of Clinical Oncology Annual Meeting (ASCO). The aim of ASCO is to share knowledge and provide updates on cancer research. By working together we hope to develop new cancer...
by Katie Nightingale | Apr 20, 2023 | Research
The British Sarcoma Group (BSG) annual conference took place on March 22nd – 23rd 2023 in Newport, Wales. We were delighted to attend as an exhibitor to promote our Osteosarcoma Now Trial Explorer (ONTEX) and our 2023 grant funding round. It was also inspiring to hear...
